|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 88.14 USD | -3.44% |
|
+2.33% | +13.22% |
| 02-03 | JPMorgan Initiates Coverage on Limbach With Neutral Rating, $100 Price Target | MT |
| 01-05 | Limbach announces appointment of new independent director | RE |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 4.09 | 3.3 | 3.18 | 6.68 | 8.07 | |||||
Return on Total Capital | 9.39 | 6.61 | 6.07 | 12.97 | 14.51 | |||||
Return On Equity % | 11.54 | 9.48 | 7.42 | 19.18 | 22.5 | |||||
Return on Common Equity | 11.54 | 9.48 | 7.42 | 19.18 | 22.5 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 14.32 | 17.52 | 18.87 | 23.1 | 27.81 | |||||
SG&A Margin | 11.19 | 14.57 | 15.68 | 16.54 | 18.74 | |||||
EBITDA Margin % | 4.11 | 4.07 | 4.52 | 7.8 | 10.46 | |||||
EBITA Margin % | 3.13 | 2.95 | 3.19 | 6.56 | 9.08 | |||||
EBIT Margin % | 3.02 | 2.85 | 2.88 | 6.2 | 8.17 | |||||
Income From Continuing Operations Margin % | 1.02 | 1.37 | 1.37 | 4.02 | 5.95 | |||||
Net Income Margin % | 1.02 | 1.37 | 1.37 | 4.02 | 5.95 | |||||
Net Avail. For Common Margin % | 1.02 | 1.37 | 1.37 | 4.02 | 5.95 | |||||
Normalized Net Income Margin | 0.76 | 1.46 | 1.57 | 3.76 | 5.15 | |||||
Levered Free Cash Flow Margin | 6.01 | -6.18 | 7.39 | 10.71 | 4.26 | |||||
Unlevered Free Cash Flow Margin | 6.58 | -5.91 | 7.6 | 10.96 | 4.47 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 2.17 | 1.85 | 1.77 | 1.72 | 1.58 | |||||
Fixed Assets Turnover | 14.07 | 12.23 | 12.7 | 13.4 | 11.25 | |||||
Receivables Turnover (Average Receivables) | 3.39 | 3.01 | 2.77 | 3.08 | 3.28 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 1.33 | 1.49 | 1.42 | 1.5 | 1.46 | |||||
Quick Ratio | 1.3 | 1.45 | 1.4 | 1.44 | 1.4 | |||||
Operating Cash Flow to Current Liabilities | 0.26 | -0.19 | 0.22 | 0.4 | 0.24 | |||||
Days Sales Outstanding (Average Receivables) | 107.93 | 121.35 | 131.92 | 118.52 | 111.7 | |||||
Average Days Payable Outstanding | 57.52 | 58.93 | 62.92 | 64.53 | 61.61 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 116.2 | 69.03 | 52.7 | 34.71 | 31.75 | |||||
Total Debt / Total Capital | 53.75 | 40.84 | 34.51 | 25.77 | 24.1 | |||||
LT Debt/Equity | 96.72 | 52.82 | 38.95 | 29.5 | 26.92 | |||||
Long-Term Debt / Total Capital | 44.74 | 31.25 | 25.51 | 21.9 | 20.43 | |||||
Total Liabilities / Total Assets | 79.5 | 67.16 | 67.6 | 60.28 | 56.41 | |||||
EBIT / Interest Expense | 1.99 | 5.45 | 7.79 | 14.75 | 23.1 | |||||
EBITDA / Interest Expense | 3.28 | 9.6 | 14.47 | 20.18 | 31.83 | |||||
(EBITDA - Capex) / Interest Expense | 3.11 | 9.3 | 13.93 | 19.14 | 27.73 | |||||
Total Debt / EBITDA | 2.2 | 2.46 | 1.9 | 0.96 | 0.83 | |||||
Net Debt / EBITDA | 0.72 | 1.87 | 0.54 | -0.41 | 0.07 | |||||
Total Debt / (EBITDA - Capex) | 2.33 | 2.54 | 1.97 | 1.01 | 0.96 | |||||
Net Debt / (EBITDA - Capex) | 0.76 | 1.93 | 0.56 | -0.43 | 0.07 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 2.69 | -13.7 | 1.31 | 3.94 | 0.47 | |||||
Gross Profit, 1 Yr. Growth % | 13.23 | 5.56 | 9.12 | 27.25 | 20.95 | |||||
EBITDA, 1 Yr. Growth % | 62.52 | -14.52 | 9.32 | 79.29 | 38.27 | |||||
EBITA, 1 Yr. Growth % | 104.21 | -18.62 | 5.23 | 113.67 | 43.14 | |||||
EBIT, 1 Yr. Growth % | 112.66 | -18.45 | -2.02 | 123.95 | 36.7 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | -427.15 | 15.62 | 1.27 | 205.25 | 48.77 | |||||
Net Income, 1 Yr. Growth % | -427.15 | 15.62 | 1.27 | 205.25 | 48.77 | |||||
Normalized Net Income, 1 Yr. Growth % | 149.96 | 65.88 | 3.53 | 149.26 | 42.34 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | -410.81 | -8.33 | -3.03 | 175 | 46.02 | |||||
Accounts Receivable, 1 Yr. Growth % | -16.13 | 13.3 | 7.34 | -19.61 | 11.89 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | -9.19 | 8.55 | -12.53 | 11.08 | 27.39 | |||||
Total Assets, 1 Yr. Growth % | 0.21 | 2.04 | 10.11 | 3.36 | 15.66 | |||||
Tangible Book Value, 1 Yr. Growth % | 26.35 | 65.81 | 15.4 | 15.73 | -0.39 | |||||
Common Equity, 1 Yr. Growth % | 14.64 | 63.47 | 8.66 | 26.69 | 26.94 | |||||
Cash From Operations, 1 Yr. Growth % | -4.4K | -160.86 | -245.97 | 62.17 | -35.88 | |||||
Capital Expenditures, 1 Yr. Growth % | -44.31 | -46.66 | 25.54 | 128.2 | 232.04 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -661.83 | -188.79 | -222.7 | 50.6 | -59.63 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -1.16K | -177.56 | -231.9 | 49.96 | -58.58 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 1.96 | -5.86 | -6.5 | 2.62 | 2.19 | |||||
Gross Profit, 2 Yr. CAGR % | 17.02 | 9.33 | 7.32 | 17.84 | 24.06 | |||||
EBITDA, 2 Yr. CAGR % | 85.85 | 17.86 | -1.89 | 40 | 55.49 | |||||
EBITA, 2 Yr. CAGR % | 175.57 | 28.92 | -5.56 | 49.95 | 72.29 | |||||
EBIT, 2 Yr. CAGR % | 300.41 | 31.69 | -8.72 | 48.13 | 72.21 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 77.41 | 94.49 | 8.2 | 75.82 | 113.1 | |||||
Net Income, 2 Yr. CAGR % | 77.41 | 94.49 | 8.2 | 75.82 | 113.1 | |||||
Normalized Net Income, 2 Yr. CAGR % | 75.63 | 103.63 | 34.44 | 60.64 | 85.3 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 17.39 | 68.79 | -5.72 | 63.3 | 100.39 | |||||
Accounts Receivable, 2 Yr. CAGR % | -4.72 | -2.52 | 10.28 | -7.11 | -5.16 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 36.86 | -0.71 | -2.55 | -1.43 | 18.95 | |||||
Total Assets, 2 Yr. CAGR % | 1.67 | 1.12 | 6 | 6.68 | 9.34 | |||||
Tangible Book Value, 2 Yr. CAGR % | 25.17 | 44.74 | 38.32 | 15.56 | 7.36 | |||||
Common Equity, 2 Yr. CAGR % | 7.65 | 36.9 | 33.28 | 17.33 | 26.82 | |||||
Cash From Operations, 2 Yr. CAGR % | 25.39 | 411.56 | -5.74 | 53.86 | 1.97 | |||||
Capital Expenditures, 2 Yr. CAGR % | -38.15 | -45.5 | -18.17 | 69.26 | 175.26 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | 22.22 | 123.35 | 3.73 | 35.93 | -22.47 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | 23.39 | 186.12 | 0.49 | 40.64 | -21.62 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 5.37 | -3.55 | -3.53 | -3.14 | 1.9 | |||||
Gross Profit, 3 Yr. CAGR % | 7.44 | 13.07 | 9.26 | 13.59 | 18.87 | |||||
EBITDA, 3 Yr. CAGR % | 15.51 | 43.46 | 16.09 | 19.95 | 38.26 | |||||
EBITA, 3 Yr. CAGR % | 22.82 | 83.51 | 22.12 | 23.98 | 46.18 | |||||
EBIT, 3 Yr. CAGR % | 41.79 | 135.58 | 21.01 | 23.12 | 42.7 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 101.29 | 53.81 | 56.46 | 52.89 | 66.29 | |||||
Net Income, 3 Yr. CAGR % | 101.29 | 53.81 | 56.46 | 52.89 | 66.29 | |||||
Normalized Net Income, 3 Yr. CAGR % | 20.06 | 72.32 | 65.32 | 65.16 | 52.62 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 76.93 | 8.1 | 40.32 | 34.71 | 57.32 | |||||
Accounts Receivable, 3 Yr. CAGR % | -1.99 | 0.94 | 0.66 | -0.75 | -1.16 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 28.98 | 26.69 | -4.82 | 1.79 | 7.37 | |||||
Total Assets, 3 Yr. CAGR % | 7.16 | 1.79 | 4.03 | 5.11 | 9.59 | |||||
Tangible Book Value, 3 Yr. CAGR % | 15.28 | 37.47 | 34.21 | 30.34 | 9.98 | |||||
Common Equity, 3 Yr. CAGR % | 3.72 | 23.73 | 26.75 | 31.04 | 20.45 | |||||
Cash From Operations, 3 Yr. CAGR % | 113.96 | -1.45 | 236.79 | 12.95 | 14.92 | |||||
Capital Expenditures, 3 Yr. CAGR % | -23.43 | -41.13 | -28.02 | 15.18 | 111.88 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 58.21 | 9.87 | 82.16 | 17.45 | -9.65 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 70.57 | 5.7 | 120.07 | 14.83 | -6.77 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 11.39 | 1.87 | 0.45 | -1.13 | -1.28 | |||||
Gross Profit, 5 Yr. CAGR % | 12.38 | 9.07 | 7.39 | 14.95 | 14.95 | |||||
EBITDA, 5 Yr. CAGR % | 17.82 | 7.87 | 8.21 | 42.91 | 30.48 | |||||
EBITA, 5 Yr. CAGR % | 18.4 | 8.98 | 10.56 | 70.65 | 40.14 | |||||
EBIT, 5 Yr. CAGR % | 17.54 | 17.25 | 18.89 | 97.33 | 39.35 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 5.84 | 29.13 | 57.03 | 62.26 | 77.04 | |||||
Net Income, 5 Yr. CAGR % | 5.84 | 29.13 | 57.03 | 62.26 | 77.04 | |||||
Normalized Net Income, 5 Yr. CAGR % | 9.17 | 34.27 | 25.62 | 69.27 | 73.04 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -21.17 | 28.28 | 37.55 | 27.5 | 61.82 | |||||
Accounts Receivable, 5 Yr. CAGR % | 7.58 | 3.48 | 2.75 | -2.36 | -1.71 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 23.8 | 17.62 | 15.3 | 14.59 | 4.06 | |||||
Total Assets, 5 Yr. CAGR % | 15.54 | 5.28 | 6.7 | 3.72 | 6.12 | |||||
Tangible Book Value, 5 Yr. CAGR % | 34.34 | 25.47 | 24 | 28.25 | 22.75 | |||||
Common Equity, 5 Yr. CAGR % | 45.61 | 13.11 | 14.66 | 21.13 | 26.78 | |||||
Cash From Operations, 5 Yr. CAGR % | 130.95 | 38.51 | 54.14 | 17.77 | 108.84 | |||||
Capital Expenditures, 5 Yr. CAGR % | -9.03 | -25.27 | -21.37 | -10.18 | 23.09 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 10.82 | 40.63 | 33.63 | 19.34 | 29.44 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 15.19 | 31.66 | 38.04 | 18.18 | 45.62 |
- Stock Market
- Equities
- LMB Stock
- Financials Limbach Holdings, Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















